Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old
Clinical trial NCT05477186 · COMPLETED
Trial details
- NCT number
- NCT05477186
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-12
- Primary completion
- 2023-08-18
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.